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Background:  Many trials define percutaneous coronary intervention-related myocardial infarction (PCI-MI) as CKMB ≥3x ULN. The appropriateness 
of this threshold is unclear and widely debated.
Methods:  Patients (pts) enrolled in SYNERGY and EARLY ACS who underwent PCI and had ≥1 biomarker measure within 24 hrs after PCI were 
analyzed. A time-dependent Cox proportional hazards model was used to estimate the hazard of 1-year death with spontaneous MI (sMI, biomarker 
level ≥2xULN) adjusting for GRACE covariates. The adjusted hazard for 1-year death with a PCI-MI was calculated using increasing peak/ULN ratios 
of CKMB to identify that peak/ULN ratios level with a similar hazard to sMI. Pts with post PCI CKMB levels <3x ULN were excluded.
Results:  Of 19,519 pts in the 2 trials, 9,358 (47.9%) were included. By day 30, sMI occurred in 275 pts (2.9%; 3.6 [1.7, 6.5] days from baseline) 
and PCI-MI in 880 (9.4%; 1.0 [0.7, 2.0] days from baseline). sMI was independently associated with 1-year death (HR 5.7 [95% CI 4.2-7.8]; 
P<0.0001). To achieve a HR for death of 5.7, a post-PCI elevation of ≈ 26.5xULN for CKMB (bounds on threshold: 10.75-60) was required (≈ HR 5.7; 
95% CI 2.8-11.4). Only 5 PCI-MI pts (0.6%) had a CKMB >26.5x ULN (Fig).
Conclusions:  sMI (biomarker≥2xULN) is strongly associated with mortality. A similar risk for PCI-MI requires a higher threshold of CKMB but the 
confidence intervals are wide. Further evaluation is needed but these findings may provide important insights about PCI-MI definitions.
